Indian Pharma at an Inflection Point: Key Takeaways from FE Pharma Summit 2026
India’s pharmaceutical sector is undergoing a high-stakes identity shift, moving from a "low-cost pharmacy" to a "value-led innovation hub." At the 3rd FE Pharma Summit 2026, industry veterans and PE investors signaled that the next phase of growth for the $60-billion industry.






















